Burden of COPD in China and the global from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019
Objective To investigate the current disease burden of chronic obstructive pulmonary disease (COPD) in China and globally using the Global Burden of Disease (GBD) data in 2019, as well as to analyse the changes in its risk factors, providing a scientific basis for the formulation of a comprehensive...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2023-07-01
|
| Series: | BMJ Open Respiratory Research |
| Online Access: | https://bmjopenrespres.bmj.com/content/10/1/e001698.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849772687067447296 |
|---|---|
| author | Min Li Ping Zhang Hanxiang Chen Na Zhou Shengnan Duan Taihua Wu Yuanyuan Yi Ni Yuan |
| author_facet | Min Li Ping Zhang Hanxiang Chen Na Zhou Shengnan Duan Taihua Wu Yuanyuan Yi Ni Yuan |
| author_sort | Min Li |
| collection | DOAJ |
| description | Objective To investigate the current disease burden of chronic obstructive pulmonary disease (COPD) in China and globally using the Global Burden of Disease (GBD) data in 2019, as well as to analyse the changes in its risk factors, providing a scientific basis for the formulation of a comprehensive prevention and control strategy for COPD in China.Study design An observational study based on the GBDs.Methods Based on the GBD 2019 database, we obtained data on incidence, prevalence, mortality, disability-adjusted life years (DALYs) and corresponding age-standardised rates of COPD in China and the global, and analysed and described the changing trends of COPD burden in China and the global from 1990 to 2019.Results In 2019, the total number of COPD deaths in China was 1.04 (95% uncertainty intervals (95% UI): 0.89–1.27) million cases, the number of patients with COPD was 45.16 (95% UI: 41.13–49.62) million cases, and the number of new cases was 4.0 (95% UI: 3.6–4.4) million cases. DALYs were 74.4 (95% UI: 68.2–80.2) million years. Compared with 1990, the number of new incident cases and the overall prevalence of COPD in China in 2019 increased by 66.20% and 66.76%, respectively, which is lower than the overall global level.Conclusion From 1990 to 2019, the age-standardized prevalence rate (ASPR), the age-standardized incidence rate (ASIR) and the age-standardized death rate (ASDR) in China and the global all showed a downward trend, and the rate of decline in China was much higher than the overall level of the world, indicating that China has made specific achievements in the prevention and treatment of COPD, but overall the disease burden of COPD is still hefty, and the number of affected individuals is still increasing. |
| format | Article |
| id | doaj-art-b9d5f6bfec4a43b7bd50f900f867d848 |
| institution | DOAJ |
| issn | 2052-4439 |
| language | English |
| publishDate | 2023-07-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | BMJ Open Respiratory Research |
| spelling | doaj-art-b9d5f6bfec4a43b7bd50f900f867d8482025-08-20T03:02:15ZengBMJ Publishing GroupBMJ Open Respiratory Research2052-44392023-07-0110110.1136/bmjresp-2023-001698Burden of COPD in China and the global from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019Min Li0Ping Zhang1Hanxiang Chen2Na Zhou3Shengnan Duan4Taihua Wu5Yuanyuan Yi6Ni Yuan71Massachusetts General Hospital, Boston, MA, USADepartment of Nephrology, Sichuan Provincial People’s Hospital, Chengdu, ChinaSchool of Public Health, Dalian Medical University, Dalian, Liaoning, ChinaDepartment of Health Policy and Management, Peking University, Beijing, ChinaSchool of Public Health, Dalian Medical University, Dalian, Liaoning, ChinaChengda Hospital, Chengda Hospital, Dalian, ChinaDepartment of Respiratory Medicine, The First Affiliated Hospital of Dalian Medical University, Dalian, ChinaSchool of Public Health, Dalian Medical University, Dalian, Liaoning, ChinaObjective To investigate the current disease burden of chronic obstructive pulmonary disease (COPD) in China and globally using the Global Burden of Disease (GBD) data in 2019, as well as to analyse the changes in its risk factors, providing a scientific basis for the formulation of a comprehensive prevention and control strategy for COPD in China.Study design An observational study based on the GBDs.Methods Based on the GBD 2019 database, we obtained data on incidence, prevalence, mortality, disability-adjusted life years (DALYs) and corresponding age-standardised rates of COPD in China and the global, and analysed and described the changing trends of COPD burden in China and the global from 1990 to 2019.Results In 2019, the total number of COPD deaths in China was 1.04 (95% uncertainty intervals (95% UI): 0.89–1.27) million cases, the number of patients with COPD was 45.16 (95% UI: 41.13–49.62) million cases, and the number of new cases was 4.0 (95% UI: 3.6–4.4) million cases. DALYs were 74.4 (95% UI: 68.2–80.2) million years. Compared with 1990, the number of new incident cases and the overall prevalence of COPD in China in 2019 increased by 66.20% and 66.76%, respectively, which is lower than the overall global level.Conclusion From 1990 to 2019, the age-standardized prevalence rate (ASPR), the age-standardized incidence rate (ASIR) and the age-standardized death rate (ASDR) in China and the global all showed a downward trend, and the rate of decline in China was much higher than the overall level of the world, indicating that China has made specific achievements in the prevention and treatment of COPD, but overall the disease burden of COPD is still hefty, and the number of affected individuals is still increasing.https://bmjopenrespres.bmj.com/content/10/1/e001698.full |
| spellingShingle | Min Li Ping Zhang Hanxiang Chen Na Zhou Shengnan Duan Taihua Wu Yuanyuan Yi Ni Yuan Burden of COPD in China and the global from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019 BMJ Open Respiratory Research |
| title | Burden of COPD in China and the global from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019 |
| title_full | Burden of COPD in China and the global from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019 |
| title_fullStr | Burden of COPD in China and the global from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019 |
| title_full_unstemmed | Burden of COPD in China and the global from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019 |
| title_short | Burden of COPD in China and the global from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019 |
| title_sort | burden of copd in china and the global from 1990 to 2019 a systematic analysis for the global burden of disease study 2019 |
| url | https://bmjopenrespres.bmj.com/content/10/1/e001698.full |
| work_keys_str_mv | AT minli burdenofcopdinchinaandtheglobalfrom1990to2019asystematicanalysisfortheglobalburdenofdiseasestudy2019 AT pingzhang burdenofcopdinchinaandtheglobalfrom1990to2019asystematicanalysisfortheglobalburdenofdiseasestudy2019 AT hanxiangchen burdenofcopdinchinaandtheglobalfrom1990to2019asystematicanalysisfortheglobalburdenofdiseasestudy2019 AT nazhou burdenofcopdinchinaandtheglobalfrom1990to2019asystematicanalysisfortheglobalburdenofdiseasestudy2019 AT shengnanduan burdenofcopdinchinaandtheglobalfrom1990to2019asystematicanalysisfortheglobalburdenofdiseasestudy2019 AT taihuawu burdenofcopdinchinaandtheglobalfrom1990to2019asystematicanalysisfortheglobalburdenofdiseasestudy2019 AT yuanyuanyi burdenofcopdinchinaandtheglobalfrom1990to2019asystematicanalysisfortheglobalburdenofdiseasestudy2019 AT niyuan burdenofcopdinchinaandtheglobalfrom1990to2019asystematicanalysisfortheglobalburdenofdiseasestudy2019 |